The North Carolina-based clinical research trial recruiting company said the purchase of Vault Health’s life sciences assets would improve its workflow processes and its metasite platform’s data interoperability capabilities, including for advanced scheduling, investigational product tracking, data exchange, electronic data capture and medical recordkeeping.

Science 37 said added capabilities from the Vault Health life sciences platform would save on costs and be cash flow neutral within the calendar year.

Science 37 shares are down 92% over the past 12 months.

Write to Chris Wack at chris.wack@wsj.com